AAAAAA

   
Results: 1-12 |
Results: 12
CONTROL OF DELAYED NAUSEA AND VOMITING WITH GRANISETRON PLUS DEXAMETHASONE OR DEXAMETHASONE ALONE IN PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY - A DOUBLE-BLIND, PLACEBO-CONTROLLED, COMPARATIVE-STUDY
Authors: GOEDHALS L HERON JF KLEISBAUER JP PAGANI O SESSA C GIGER K CAVALLI F LUDWIG C AAPRO M BLEIBERG H DEWASH G DICATO M TAGNON A VANSTRAELEN D VINDEVOGHEL A ABRATT R FALKSON G BARLEY V CARMICHAEL J COLEMAN R DAVIDSON N GRIEVE R HARPER P ROBERTS J RUSTIN G NAMAN H SCHNEIDER M NOBLE A NETTER P CUPISSOL D BALMES P CALS L KHAYAT D CATIMEL G DUTIN JP BOUFETTE P ADENIS L MISSET J COLLERY P NOUVET G CHAVAILLON JM BLANCHON F POIRIER R ARNAUD A LECAER H CARLES P MUIR J BONNAUD F MARQUESTE L CLAVIER J GUERIN J TAYTARD A KEIZER H NORTIER J SLEE P WILS J RODENBURG C BURGHOUTS J DEWIT R GARCIAGIRON C JIMENEZLACAVE A CRUZHERNANDEZ J MASSUTISUREDA B HANS K FUCHS R KRIEGMAIR M SCHULLER J LAHOUSEN M PANNUTI F MONFARDINI S NILSSON S
Citation: L. Goedhals et al., CONTROL OF DELAYED NAUSEA AND VOMITING WITH GRANISETRON PLUS DEXAMETHASONE OR DEXAMETHASONE ALONE IN PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY - A DOUBLE-BLIND, PLACEBO-CONTROLLED, COMPARATIVE-STUDY, Annals of oncology, 9(6), 1998, pp. 661-666
COST-EFFECTIVENESS ANALYSIS OF 2 STRATEGIES OF TREATMENT FOR STAGE-III NON SURGICAL NON-SMALL-CELL LUNG-CANCER
Authors: VERGNENEGRE A DAURES JP BALMES P BLANCHON F BONNAUD F CARLES P CLAVIER J ROBINET G GUERIN JC PEROL M KLEISBAUER JP THOMAS P MUIR JF PAILLOTIN D POIRIER R TAYTARD A
Citation: A. Vergnenegre et al., COST-EFFECTIVENESS ANALYSIS OF 2 STRATEGIES OF TREATMENT FOR STAGE-III NON SURGICAL NON-SMALL-CELL LUNG-CANCER, European journal of cancer, 33, 1997, pp. 67-67
ANALYTICAL STUDY OF MARKERS .3. CARCINOEM BRYONIC ANTIGEN
Authors: BLANCHON F
Citation: F. Blanchon, ANALYTICAL STUDY OF MARKERS .3. CARCINOEM BRYONIC ANTIGEN, Revue des maladies respiratoires, 14, 1997, pp. 30-31
CEFIXIM VERSUS AMOXICILLIN-CLAVULANATE IN THE TREATMENT OF ACUTE EXACERBATION OF CHRONIC-BRONCHITIS, IN PATIENTS WITH RISK-FACTORS
Authors: ZUCK P RIO Y TRINH A DELAVAULT P PETITFRERE I CLAUDE JL CROCE C CAUBEL F DOVAN R GROSSIER JM HENLE D KOCH C MULLER D PERREIN C PIERRON J PRIME T RICHTER D ROSZAK E MONIEZ D DOURNOVO P MONTEAU N CAVALIER B ALLEGRINI C GRIMALDI JF GUERIN P GUIRAUD JP PUGET A LEONARDELLI M ALFIERISIADOUS M BERACASSAT C DAVIGNON J GIRARD D PELLETIER M NAUDIN G VINCENT J FERRU J ABITBOL JP AVAKIAN A BENEVISE B CONNAN JB DEVALMONT D SAUTEREAU O HERMAN D LAUBY M BALTUS C GAILLARD JR PLAN P ROLLAND C TAURILPIBRE EL VIDAL M GARCIN L LIEB F LIEBBAZILE C AURIOL P CAUSSE P DADOLLE C PARTRAT Y PRIEUR T VERGNON JM ROS A HANRION P PLANEL P BERAUD A HOUPPERT Y DUPONT B FOUCHARD JL MANTOVANI M SILVAIN C DEBIEUVRE D CHANTELAT P BLANCHON F GRIGNET JP ROYER E AMAR P BENSOUSSAN R BISMUTH D BRILLAUX F DORFMANN M DUCLOS G FONTAINE M GARCON G GIRARD P GUTH PC KICHELEWSKI S LEVY D NEDELEC P VASSEUR G WALTER P BEAUCE A TRAN VT LABESCAT J COMPAN D SCHEIMBERG A MOURET G DEPEUFEILHOUX A MENZEL R
Citation: P. Zuck et al., CEFIXIM VERSUS AMOXICILLIN-CLAVULANATE IN THE TREATMENT OF ACUTE EXACERBATION OF CHRONIC-BRONCHITIS, IN PATIENTS WITH RISK-FACTORS, Medecine et maladies infectieuses, 27(5), 1997, pp. 603-610
COMPARISON OF SALMETEROL WITH DISODIUM-CROMOGLYCATE IN THE TREATMENT OF ADULT ASTHMA
Authors: BOUSQUET J AUBERT B BONS J ANTIPHON P BARGAT F BLANCHON F BUGNAS B CAMILLERI G CHANAS M CHAPPARD C CHAVEZ L CHEVAILLON JM CLAVIER J DELHOUME JY DURAND G GREILLIER P GROUFFAL C GUILLAIS P HUTT N ICKOVIC MR LARZUL JJ LAVANDIER M LEBAS FX LEGOLF C LELOET C LUGASSY D MARTINAT Y MULLE D PENET A PIQUET J PROSPER M PRUDHOMME A PUJET JC SEIGNALET C SEVETTE C STERN M TERDJMANN JP VINCENT J ZUCK P
Citation: J. Bousquet et al., COMPARISON OF SALMETEROL WITH DISODIUM-CROMOGLYCATE IN THE TREATMENT OF ADULT ASTHMA, Annals of allergy, asthma, & immunology, 76(2), 1996, pp. 189-194
COMPARATIVE EFFICACY OF SPARFLOXACIN IN COMPARISON WITH AMOXICILLIN PLUS OFLOXACIN IN THE TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA
Authors: PORTIER H MAY T PROUST A TOLSTUCHOW N MUIR JF BALMES P",PAGANIN,"CARLES P BLANCHON F ROCHEMAURE J TONNEL AB DUMONT P WALLAERT C RAGNAUD JM BECQGIRAUDON B NOUVET G WEITZENBLUM E LENG B GAILLAT J DEFOUILLOY C ARNAUD A HERER B MIECH G MODAI J CREPIN JL BERNARD P CORDIER JF BART F CLAVIER J STAHL JP POLU JM LACROIX S JEANNIN L BENOIT JP BALGARIES JL BARBIEUX H BEYTOUT J PARIENTE R PATEY O RAFFI F TUCHAIS E SERGEANT YH CHOUTET P CAILLAUX D
Citation: H. Portier et al., COMPARATIVE EFFICACY OF SPARFLOXACIN IN COMPARISON WITH AMOXICILLIN PLUS OFLOXACIN IN THE TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA, Journal of antimicrobial chemotherapy, 37, 1996, pp. 83-91
COST-ANALYSIS OF HOSPITAL TREATMENT - 2 CHEMOTHERAPIC REGIMENS FOR NONSURGICAL NON-SMALL-CELL LUNG-CANCER
Authors: VERGNENEGRE A PEROL M PHAM E BALMES P BLANCHON F BONNAUD F CARLES P CLAVIER J GUERIN JC KLEISBAUER JP MUIR JF PAILLOTIN D POIRIER R TAYTARD A
Citation: A. Vergnenegre et al., COST-ANALYSIS OF HOSPITAL TREATMENT - 2 CHEMOTHERAPIC REGIMENS FOR NONSURGICAL NON-SMALL-CELL LUNG-CANCER, Lung cancer, 14(1), 1996, pp. 31-44
IS NAVOBAN(R) (TROPISETRON) AS EFFECTIVE AS ZOFRAN(R) (ONDANSETRON) IN CISPLATIN-INDUCED EMESIS
Authors: MARTY M KLEISBAUER JP FOURNEL P VERGNENEGRE A CARLES P LORIAKANZA Y SIMONETTA C DEBRUIJN KM LAURAINE P DIDIER A CUPISSOL D BERGERAT JP PUJAZON MC HERON JF DRENO B TAYTARD A GUERIN JC CLAVIER J ROBINET G BLANCHON F BALMES P MUIR JF PAILLOTIN D POIRIER R BONNETERRE J MELLONI B ROCHE H DEPIERRE A PLAGNE R SOUQUET PJ ARMAND JP DEFORNI M
Citation: M. Marty et al., IS NAVOBAN(R) (TROPISETRON) AS EFFECTIVE AS ZOFRAN(R) (ONDANSETRON) IN CISPLATIN-INDUCED EMESIS, Anti-cancer drugs, 6, 1995, pp. 15-21
CARBOPLATIN PLUS ORAL ETOPOSIDE IN ELDERL Y PATIENTS WITH NONSMALL-CELL LUNG-CANCER - A STUDY OF THE GROUPE-FRANCAIS-DE-PNEUMOCANCEROLOGIE (GFPC)
Authors: CASTELNAU O PEROL M VERGNENEGRE A BLANCHON F AMAUD A TAYTARD A GUERIN JC BONNAUD F KLEISBAUER JP
Citation: O. Castelnau et al., CARBOPLATIN PLUS ORAL ETOPOSIDE IN ELDERL Y PATIENTS WITH NONSMALL-CELL LUNG-CANCER - A STUDY OF THE GROUPE-FRANCAIS-DE-PNEUMOCANCEROLOGIE (GFPC), Bulletin du cancer, 82(1), 1995, pp. 63-66
VINORELBINE VERSUS VINORELBINE PLUS CISPLATIN IN ADVANCED NONSMALL CELL LUNG-CANCER - A RANDOMIZED TRIAL
Authors: DEPIERRE A CHASTANG C QUOIX E LEBEAU B BLANCHON F PAILLOT N LEMARIE E MILLERON B MORO D CLAVIER J HERMAN D TUCHAIS E JACOULET P BRECHOT JM CORDIER JF SOLALCELIGNY P BADRI N BESENVAL M
Citation: A. Depierre et al., VINORELBINE VERSUS VINORELBINE PLUS CISPLATIN IN ADVANCED NONSMALL CELL LUNG-CANCER - A RANDOMIZED TRIAL, Annals of oncology, 5(1), 1994, pp. 37-42
SMALL-CELL LUNG-CANCER - PATIENTS SURVIVING LONGER THAN 30 MONTHS
Authors: MORO D JACOULET P QUOIX E RANFAING E BRAMBILLA E CAPRON F LAGRANGE JL MILLERON B LEBEAU B RUFFIE P RIVIERE A BLANCHON F GERAADS A DEPIERRE A
Citation: D. Moro et al., SMALL-CELL LUNG-CANCER - PATIENTS SURVIVING LONGER THAN 30 MONTHS, Anticancer research, 14(1B), 1994, pp. 301-304
SALMETEROL COMPARED WITH SLOW-RELEASE TERBUTALINE IN NOCTURNAL ASTHMA- A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, SEQUENTIAL CLINICAL-TRIAL
Authors: BRAMBILLA C CHASTANG C GEORGES D BERTIN L DESFOUGERES JL ANTIPHON P AUBIER M BARBIER R BELLVERT P BLANCHON F BONNAMOUR C BOUTRY D CABRERA J CARLES P CHAMAS M CHARPIN D CHAVAILLON JM CLAVIER J COSTE E CROXO C DELECLUSE P DENNEWALD G DERENNE JP EPSTEIN M FIAUD JP GAILLARD JR GAUCHER L GREILLIER P GRIGNET JP GROSCLAUDE M GRUNCHEC N GUERIN P GUILLAIS P KRAI D LAVANDIER M LEBAS FX LECOCGUIC Y LEGENDRE M LEGOFF C LUGASSY D MAFFRE JP MARTIN M MATHIEU M MEEKEL P MORALES R MULLER D PERRINFAYOLLE M PRUDHOMME A REMAN A STERN M TRINQUET G WATRIGANT Y ZUCK P
Citation: C. Brambilla et al., SALMETEROL COMPARED WITH SLOW-RELEASE TERBUTALINE IN NOCTURNAL ASTHMA- A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, SEQUENTIAL CLINICAL-TRIAL, Allergy, 49(6), 1994, pp. 421-426
Risultati: 1-12 |